Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

Mallinckrodt plc United Kingdom Ireland

and http://www.mallinckrodt.com respectively, identify and describe in more detail the risks and uncertainties to which Mallinckrodt's businesses are subject. The forward-looking statements made herein speak only as of the date hereof and Mallinckrodt does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise, except as required by law.

CONTACTS

Investor Relations
Daniel Speciale
Senior Vice President, Finance and CFO, Specialty Generics
[phone]
[e-mail]

Derek Belz
Vice President, Investor Relations
[phone]
[e-mail]

Media
Michael Freitag / Aaron Palash / Aura Reinhard / Catherine Simon
Joele Frank, Wilkinson Brimmer Katcher
[phone]

Government Affairs
Derek Naten
Vice President, Government Affairs
[phone]
[e-mail]

Mallinckrodt, the "M" brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. ©2023.

Logo - https://mma.prnewswire.com/media/167103/mallinckrodt_plc_logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/mallinckrodt-completes-financial-restructuring-and-irish-examinership-proceedings-and-emerges-from-chapter-11-301988306.html